Kidney Precision Medicine Project Central Hub (U24 Clinical Trial Not Allowed)

The summary for the Kidney Precision Medicine Project Central Hub (U24 Clinical Trial Not Allowed) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Kidney Precision Medicine Project Central Hub (U24 Clinical Trial Not Allowed): This Notice of Funding Opportunity (NOFO) requests applications for the Kidney Precision Medicine Project (KPMP) Central Hub (CH) to lead a unified effort to discover and define new acute and chronic kidney disease pathways and subgroups that enable precision clinical trials. The CH will provide strategic leadership for the entire KPMP and steward advanced computational analyses, data management and sharing, communication and outreach, and business operations to realize the vision of the KPMP. All KPMP personnel will actively participate in scientific discovery and promote open science.

Federal Grant Title:	Kidney Precision Medicine Project Central Hub (U24 Clinical Trial Not Allowed)
Federal Agency Name:	National Institutes of Health (HHS-NIH11)
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-DK-27-303
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.847
CFDA Descriptions:	Information not provided
Current Application Deadline:	July 10th, 2026
Original Application Deadline:	July 10th, 2026
Posted Date:	June 3rd, 2026
Creation Date:	June 3rd, 2026
Archive Date:	September 8th, 2026
Total Program Funding:	$5,000,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:	1
Cost Sharing or Matching:	No
Last Updated:	June 3rd, 2026

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility: Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/Foreign Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Grant Announcement Contact: Division of Kidney, Urologic, and Hematologic Diseases
[email protected]
[email protected]
Similar Government Grants: • Nutrition Obesity Research Centers (NORCs) (P30 Clinical Trial Optional); • Silvio O. Conte Digestive Diseases Research Core Centers (P30-Clinical Trial Optional); • Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Ad...; • Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Ad...; • Kidney Precision Medicine Project Tissue Interrogation Sites (U01 Clinical Trial Not Allow...; • Proteomic and Metabolomic Approaches to Diagnose Diabetes and Pre-Diabetes; • Molecular Therapy Core Centers; • Pilot and Feasibility Program in Human Islet Biology
More Grants from the National Institutes of Health: • Research Centers in Minority Institutions (RCMI) Coordinating Center (U24 - Clinical Trial...; • Single Source: Post-Stroke Vascular Contributions to Cognitive Impairment and Dementia (VC...; • Nutrition Obesity Research Centers (NORCs) (P30 Clinical Trial Optional); • Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal ...; • PRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine...